A case developing minimal change disease during the course of IgG4-related disease

We describe a 66-year-old male with immunoglobulin G4-related disease (IgG4-RD) presenting with minimal change disease (MCD). Three years prior to this admission, the patient had been diagnosed with IgG4-RD. The development of sudden massive proteinuria (4+; 16.7 g/gCr) with a weight gain of 8 kg wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Modern rheumatology 2017-07, Vol.27 (4), p.712-715
Hauptverfasser: Yamada, Kazunori, Zoshima, Takeshi, Ito, Kiyoaki, Mizushima, Ichiro, Hara, Satoshi, Horita, Shigeto, Nuka, Hiromi, Hamano, Ryoko, Fujii, Hiroshi, Yamagishi, Masakazu, Kawano, Mitsuhiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 715
container_issue 4
container_start_page 712
container_title Modern rheumatology
container_volume 27
creator Yamada, Kazunori
Zoshima, Takeshi
Ito, Kiyoaki
Mizushima, Ichiro
Hara, Satoshi
Horita, Shigeto
Nuka, Hiromi
Hamano, Ryoko
Fujii, Hiroshi
Yamagishi, Masakazu
Kawano, Mitsuhiro
description We describe a 66-year-old male with immunoglobulin G4-related disease (IgG4-RD) presenting with minimal change disease (MCD). Three years prior to this admission, the patient had been diagnosed with IgG4-RD. The development of sudden massive proteinuria (4+; 16.7 g/gCr) with a weight gain of 8 kg within a two-week period was noted, and nephrotic syndrome was suspected. The patient's serum IgG4 level did not increase and hypocomplementemia was not found. A renal biopsy showed no cellular infiltration in the renal interstitium, and no spiking or bubbling was found on periodic acid methenamine silver staining. On electron microscopy, foot process effacement was seen, but no subepithelial electron-dense deposits were found. The patient was diagnosed with MCD. Ten days after starting prednisolone (60 mg/day), proteinuria was negative. Since IgG4-RD and MCD share a T-helper 2-dominant immunoreaction, the development of MCD in IgG4-RD patients may reflect more than a mere coincidence.
doi_str_mv 10.3109/14397595.2015.1019958
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826618020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826618020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-9bd89e62009533aeb3eef4f899efcaff8970b8de460dc8cbf5dd8f0a8ac8fe103</originalsourceid><addsrcrecordid>eNo9kE1PwzAMQCMEYjD4CaAeuXQkTdPGx2mCMWkSEoJzlCbOVtSPkbRI_HtatnKyZT_b8iPkjtEFZxQeWcohFyAWCWViwSgDEPKMXI31OM8onE_5AM3IdQiflHIBEi7JLBE5z7iQV-RtGRkdMLL4jVV7KJtdVJdNWesqMnvd7IZOGfCP6P3Y7fYYmbb3Q6V10Wa3TmOPle7QTuQNuXC6Cnh7inPy8fz0vnqJt6_rzWq5jQ0H6GIorATMEkpBcK6x4IgudRIAndFuSHJaSItpRq2RpnDCWumoltpIh4zyOXk47j349qvH0Km6DAarSjfY9kExmWQZkzQZUXFEjW9D8OjUwQ8_-h_FqBp1qkmnGnWqk85h7v50oi9qtP9Tkz_-CzwQcRY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826618020</pqid></control><display><type>article</type><title>A case developing minimal change disease during the course of IgG4-related disease</title><source>MEDLINE</source><source>Oxford University Press Journals Current</source><creator>Yamada, Kazunori ; Zoshima, Takeshi ; Ito, Kiyoaki ; Mizushima, Ichiro ; Hara, Satoshi ; Horita, Shigeto ; Nuka, Hiromi ; Hamano, Ryoko ; Fujii, Hiroshi ; Yamagishi, Masakazu ; Kawano, Mitsuhiro</creator><creatorcontrib>Yamada, Kazunori ; Zoshima, Takeshi ; Ito, Kiyoaki ; Mizushima, Ichiro ; Hara, Satoshi ; Horita, Shigeto ; Nuka, Hiromi ; Hamano, Ryoko ; Fujii, Hiroshi ; Yamagishi, Masakazu ; Kawano, Mitsuhiro</creatorcontrib><description>We describe a 66-year-old male with immunoglobulin G4-related disease (IgG4-RD) presenting with minimal change disease (MCD). Three years prior to this admission, the patient had been diagnosed with IgG4-RD. The development of sudden massive proteinuria (4+; 16.7 g/gCr) with a weight gain of 8 kg within a two-week period was noted, and nephrotic syndrome was suspected. The patient's serum IgG4 level did not increase and hypocomplementemia was not found. A renal biopsy showed no cellular infiltration in the renal interstitium, and no spiking or bubbling was found on periodic acid methenamine silver staining. On electron microscopy, foot process effacement was seen, but no subepithelial electron-dense deposits were found. The patient was diagnosed with MCD. Ten days after starting prednisolone (60 mg/day), proteinuria was negative. Since IgG4-RD and MCD share a T-helper 2-dominant immunoreaction, the development of MCD in IgG4-RD patients may reflect more than a mere coincidence.</description><identifier>ISSN: 1439-7595</identifier><identifier>EISSN: 1439-7609</identifier><identifier>DOI: 10.3109/14397595.2015.1019958</identifier><identifier>PMID: 25736358</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Autoimmune Diseases - complications ; Glucocorticoids - therapeutic use ; Humans ; Immunoglobulin G - blood ; Male ; Nephrosis, Lipoid - blood ; Nephrosis, Lipoid - complications ; Nephrosis, Lipoid - drug therapy ; Nephrosis, Lipoid - immunology ; Prednisolone - therapeutic use ; Proteinuria - blood ; Proteinuria - complications ; Proteinuria - drug therapy ; Proteinuria - immunology ; Treatment Outcome</subject><ispartof>Modern rheumatology, 2017-07, Vol.27 (4), p.712-715</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-9bd89e62009533aeb3eef4f899efcaff8970b8de460dc8cbf5dd8f0a8ac8fe103</citedby><cites>FETCH-LOGICAL-c399t-9bd89e62009533aeb3eef4f899efcaff8970b8de460dc8cbf5dd8f0a8ac8fe103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25736358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Kazunori</creatorcontrib><creatorcontrib>Zoshima, Takeshi</creatorcontrib><creatorcontrib>Ito, Kiyoaki</creatorcontrib><creatorcontrib>Mizushima, Ichiro</creatorcontrib><creatorcontrib>Hara, Satoshi</creatorcontrib><creatorcontrib>Horita, Shigeto</creatorcontrib><creatorcontrib>Nuka, Hiromi</creatorcontrib><creatorcontrib>Hamano, Ryoko</creatorcontrib><creatorcontrib>Fujii, Hiroshi</creatorcontrib><creatorcontrib>Yamagishi, Masakazu</creatorcontrib><creatorcontrib>Kawano, Mitsuhiro</creatorcontrib><title>A case developing minimal change disease during the course of IgG4-related disease</title><title>Modern rheumatology</title><addtitle>Mod Rheumatol</addtitle><description>We describe a 66-year-old male with immunoglobulin G4-related disease (IgG4-RD) presenting with minimal change disease (MCD). Three years prior to this admission, the patient had been diagnosed with IgG4-RD. The development of sudden massive proteinuria (4+; 16.7 g/gCr) with a weight gain of 8 kg within a two-week period was noted, and nephrotic syndrome was suspected. The patient's serum IgG4 level did not increase and hypocomplementemia was not found. A renal biopsy showed no cellular infiltration in the renal interstitium, and no spiking or bubbling was found on periodic acid methenamine silver staining. On electron microscopy, foot process effacement was seen, but no subepithelial electron-dense deposits were found. The patient was diagnosed with MCD. Ten days after starting prednisolone (60 mg/day), proteinuria was negative. Since IgG4-RD and MCD share a T-helper 2-dominant immunoreaction, the development of MCD in IgG4-RD patients may reflect more than a mere coincidence.</description><subject>Aged</subject><subject>Autoimmune Diseases - complications</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Humans</subject><subject>Immunoglobulin G - blood</subject><subject>Male</subject><subject>Nephrosis, Lipoid - blood</subject><subject>Nephrosis, Lipoid - complications</subject><subject>Nephrosis, Lipoid - drug therapy</subject><subject>Nephrosis, Lipoid - immunology</subject><subject>Prednisolone - therapeutic use</subject><subject>Proteinuria - blood</subject><subject>Proteinuria - complications</subject><subject>Proteinuria - drug therapy</subject><subject>Proteinuria - immunology</subject><subject>Treatment Outcome</subject><issn>1439-7595</issn><issn>1439-7609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1PwzAMQCMEYjD4CaAeuXQkTdPGx2mCMWkSEoJzlCbOVtSPkbRI_HtatnKyZT_b8iPkjtEFZxQeWcohFyAWCWViwSgDEPKMXI31OM8onE_5AM3IdQiflHIBEi7JLBE5z7iQV-RtGRkdMLL4jVV7KJtdVJdNWesqMnvd7IZOGfCP6P3Y7fYYmbb3Q6V10Wa3TmOPle7QTuQNuXC6Cnh7inPy8fz0vnqJt6_rzWq5jQ0H6GIorATMEkpBcK6x4IgudRIAndFuSHJaSItpRq2RpnDCWumoltpIh4zyOXk47j349qvH0Km6DAarSjfY9kExmWQZkzQZUXFEjW9D8OjUwQ8_-h_FqBp1qkmnGnWqk85h7v50oi9qtP9Tkz_-CzwQcRY</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Yamada, Kazunori</creator><creator>Zoshima, Takeshi</creator><creator>Ito, Kiyoaki</creator><creator>Mizushima, Ichiro</creator><creator>Hara, Satoshi</creator><creator>Horita, Shigeto</creator><creator>Nuka, Hiromi</creator><creator>Hamano, Ryoko</creator><creator>Fujii, Hiroshi</creator><creator>Yamagishi, Masakazu</creator><creator>Kawano, Mitsuhiro</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>A case developing minimal change disease during the course of IgG4-related disease</title><author>Yamada, Kazunori ; Zoshima, Takeshi ; Ito, Kiyoaki ; Mizushima, Ichiro ; Hara, Satoshi ; Horita, Shigeto ; Nuka, Hiromi ; Hamano, Ryoko ; Fujii, Hiroshi ; Yamagishi, Masakazu ; Kawano, Mitsuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-9bd89e62009533aeb3eef4f899efcaff8970b8de460dc8cbf5dd8f0a8ac8fe103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Autoimmune Diseases - complications</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Humans</topic><topic>Immunoglobulin G - blood</topic><topic>Male</topic><topic>Nephrosis, Lipoid - blood</topic><topic>Nephrosis, Lipoid - complications</topic><topic>Nephrosis, Lipoid - drug therapy</topic><topic>Nephrosis, Lipoid - immunology</topic><topic>Prednisolone - therapeutic use</topic><topic>Proteinuria - blood</topic><topic>Proteinuria - complications</topic><topic>Proteinuria - drug therapy</topic><topic>Proteinuria - immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Kazunori</creatorcontrib><creatorcontrib>Zoshima, Takeshi</creatorcontrib><creatorcontrib>Ito, Kiyoaki</creatorcontrib><creatorcontrib>Mizushima, Ichiro</creatorcontrib><creatorcontrib>Hara, Satoshi</creatorcontrib><creatorcontrib>Horita, Shigeto</creatorcontrib><creatorcontrib>Nuka, Hiromi</creatorcontrib><creatorcontrib>Hamano, Ryoko</creatorcontrib><creatorcontrib>Fujii, Hiroshi</creatorcontrib><creatorcontrib>Yamagishi, Masakazu</creatorcontrib><creatorcontrib>Kawano, Mitsuhiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Modern rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Kazunori</au><au>Zoshima, Takeshi</au><au>Ito, Kiyoaki</au><au>Mizushima, Ichiro</au><au>Hara, Satoshi</au><au>Horita, Shigeto</au><au>Nuka, Hiromi</au><au>Hamano, Ryoko</au><au>Fujii, Hiroshi</au><au>Yamagishi, Masakazu</au><au>Kawano, Mitsuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case developing minimal change disease during the course of IgG4-related disease</atitle><jtitle>Modern rheumatology</jtitle><addtitle>Mod Rheumatol</addtitle><date>2017-07</date><risdate>2017</risdate><volume>27</volume><issue>4</issue><spage>712</spage><epage>715</epage><pages>712-715</pages><issn>1439-7595</issn><eissn>1439-7609</eissn><abstract>We describe a 66-year-old male with immunoglobulin G4-related disease (IgG4-RD) presenting with minimal change disease (MCD). Three years prior to this admission, the patient had been diagnosed with IgG4-RD. The development of sudden massive proteinuria (4+; 16.7 g/gCr) with a weight gain of 8 kg within a two-week period was noted, and nephrotic syndrome was suspected. The patient's serum IgG4 level did not increase and hypocomplementemia was not found. A renal biopsy showed no cellular infiltration in the renal interstitium, and no spiking or bubbling was found on periodic acid methenamine silver staining. On electron microscopy, foot process effacement was seen, but no subepithelial electron-dense deposits were found. The patient was diagnosed with MCD. Ten days after starting prednisolone (60 mg/day), proteinuria was negative. Since IgG4-RD and MCD share a T-helper 2-dominant immunoreaction, the development of MCD in IgG4-RD patients may reflect more than a mere coincidence.</abstract><cop>United States</cop><pmid>25736358</pmid><doi>10.3109/14397595.2015.1019958</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1439-7595
ispartof Modern rheumatology, 2017-07, Vol.27 (4), p.712-715
issn 1439-7595
1439-7609
language eng
recordid cdi_proquest_miscellaneous_1826618020
source MEDLINE; Oxford University Press Journals Current
subjects Aged
Autoimmune Diseases - complications
Glucocorticoids - therapeutic use
Humans
Immunoglobulin G - blood
Male
Nephrosis, Lipoid - blood
Nephrosis, Lipoid - complications
Nephrosis, Lipoid - drug therapy
Nephrosis, Lipoid - immunology
Prednisolone - therapeutic use
Proteinuria - blood
Proteinuria - complications
Proteinuria - drug therapy
Proteinuria - immunology
Treatment Outcome
title A case developing minimal change disease during the course of IgG4-related disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A12%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20developing%20minimal%20change%20disease%20during%20the%20course%20of%20IgG4-related%20disease&rft.jtitle=Modern%20rheumatology&rft.au=Yamada,%20Kazunori&rft.date=2017-07&rft.volume=27&rft.issue=4&rft.spage=712&rft.epage=715&rft.pages=712-715&rft.issn=1439-7595&rft.eissn=1439-7609&rft_id=info:doi/10.3109/14397595.2015.1019958&rft_dat=%3Cproquest_cross%3E1826618020%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826618020&rft_id=info:pmid/25736358&rfr_iscdi=true